Biotoscana Agrees To Acquire United Medical To Expand Commercial Presence In Brazil And Create A Leading Regional Specialty Pharmaceutical Company In South America

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOGOTÁ, Colombia & SÃO PAULO--(BUSINESS WIRE)--Grupo Biotoscana SL, a pharmaceutical company based in Bogotá, Colombia, and majority owned by Advent International and Essex Woodlands, today announced that it has signed an agreement to acquire United Medical, a group of pharmaceutical companies based in São Paulo, Brazil, to create a leading specialty pharmaceutical company with commercialization capabilities throughout South America. The acquisition will broaden Biotoscana’s portfolio of innovative licensed products as well as its geographic sales and marketing capabilities by expanding into the $28 billion Brazilian pharmaceutical market.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC